Risk factors for the progression of microalbuminuria in Japanese type 2 diabetic patients - A 10-year follow-up study

Diabetes Research and Clinical Practice

Volumn 46, Issue 1, 1999, Pages 47-55

  Oue, Takanori ^a   Namba, Mitsuyoshi ^a   Nakajima, Hiromu ^a   Ono, Akira ^a   Horikawa, Yukio ^a   Yamamoto, Koji ^a   Hamaguchi, Tomoya ^a   Fujino Kurihara, Hiroko ^a   Yamasaki, Tomoyuki ^a   Tomita, Koji ^a   Miyagawa, Jun Ichiro ^a   Hanafusa, Toshiaki ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Angiotensin I converting enzyme (ACE) gene; Angiotensinogen (AGT) gene; Longitudinal study; Microalbuminuria; Progression; Risk factor

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; HUMAN; JAPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; URINALYSIS;

ADULT; AGED; ALBUMINURIA; ANGIOTENSINOGEN; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GENOTYPE; HUMANS; HYPERTENSION; JAPAN; LONGITUDINAL STUDIES; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0032829773     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00068-6     Document Type: Article

References (37)

1. Japanese Society for Dialysis Therapy, An overview of regular dialysis treatment in Japan, J. Jpn. Soc. Dial. Ther. 29 (1996) 1-22.
2. Krolewski A.S., Canessa M., Warram J.H. et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. New Engl. J. Med. 318:1988;140-145.
3. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin I-converting enzyme inhibition on diabetic nephropathy, the collaborative study group. New Engl. J. Med. 329:1993;1456-1462.
4. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1990;1343-1346.
5. Costerousse O., Allegrini J., Lopez M., Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290:1993;33-40.
6. Schunkert H., Hense H.W., Holmer S.R. et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. New Engl. J. Med. 330:1994;1634-1638.
7. Cambien F., Poirier O., Leecerf L. et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
8. Markus H.S., Barley J., Lunt R. et al. Angiotensin-converting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke. 26:1995;1329-1333.
9. Juenemaitre X., Soubrier F., Kotelevtsev Y.V. et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:1992;169-180.
10. Marre M., Bernadet P., Gallois Y. et al. Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 43:1994;384-388.
11. Tarnow L., Cambien F., Rossing P. et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 44:1995;489-494.
12. Mizuiri S., Hemmi H., Inoue A. et al. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron. 70:1995;455-459.
13. Dudley C.R.K., Keavney B., Stratton I.M., Turner R.C., Ratcliffe P. UK Prospective Diabetes Study XV, relationship of rennin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int. 48:1995;1907-1911.
14. Doi Y., Yoshizumi H., Yoshinari M. et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complication in Japanese patients with NIDDM. Diabetologia. 39:1996;97-102.
15. Ohno T., Kawazu S., Tomono S. et al. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen gene with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism. 45:1996;218-222.
16. Fogarty D.G, Harron J.C., Hughes A.E., Nevin N.C., Doherty C.C., Maxwell A.P. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes. 45:1996;1204-1208.
17. Tarnow L., Cambien F., Rossing P. et al. Angiotensinogen gene polymorphisms in NIDDM patients with diabetic nephropathy. Diabetes. 45:1996;367-369.
18. Yoshida H., Kuriyama S., Atsumi Y. et al. Angiotensin I converting enzyme gene polymorphism in non-insulin-dependent diabetes mellitus. Kidney Int. 50:1996;657-664.
19. American Diabetes Association, Diabetic nephropathy, Diabetes Care 21 (1998) S50-S53.
20. D. Koya, M. Haneda, T. Ishida, H. Nakagawa, M. Takikita, R. Kikkawa, Cot-off value of microalbuminaria for predicting later progression to overt diabetic nephropathy, J. Jap. Diab. Soc. 41 (1998) 749-750 (Japanese).
21. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene DCP1 (dipeptidyl carboxypeptidase 1). Nucl. Acid. Res. 20:1992;1433.
22. Shanmugam V., Sell K.W., Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3:1993;120-121.
23. Russ A.P., Maertz W., Ruzicka V., Stein U., Gross W. Rapid detection of the hypertension-associated Met 235-Thr allele of the human angiotensinogen gene. Hum. Mol. Genet. 2:1993;609-610.
24. Marshall S.M. Screening for microalbuminuria: which measurement? Diabetic Med. 8:1991;706-711.
25. Nelson R.G., Bennett P.H., Beck G.J. et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. New Eng. J. Med. 335:1996;1636-1642.
26. Schmitz A., Vaeth M. Microalbuminuria, a major risk factor in non-insulin-dependent diabetes, a 10-year follow-up study of 503 patients. Diabetic Med. 5:1988;126-134.
27. Klein R., Klein B.E.K., Moss S.E. Prevalence of microalbuminuria in older -onset diabetes. Diabetes Care. 16:1993;1325-1329.
28. Gall M.A., Rossing P., Skott P. et al. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 34:1991;655-661.
29. Olivarius N., Andreasen A.H., Keiding N., Mogensen C.E. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients: cross-sectional data from the population-based study 'Diabetes care in general practice', Denmark. Diabetologia. 36:1993;1007-1016.
30. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med. 329 (1993) 977-986.
31. Reichard P., Pihl M., Rosenqvist U., Sule J. Complication in IDDM are caused by elevated blood glucose level: the Stockholm diabetes intervention study (SDIS) at 10-year follow up. Diabetologia. 39:1996;1483-1488.
32. Ohkubo Y., Kishikawa H., Araki E. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab. Res. Clin. Pract. 28:1995;103-117.
33. Alzaid Aus A. Microalbuminuria in patients with NIDDM, an overview. Diabetes Care. 19:1996;79-89.
34. Ballard D.J., Humpfrey L.L., Palumbo P.J. et al. Epidemiology of persistent proteinuria in type II diabetes mellitus, population-based study in Rochester Minnesota. Diabetes. 37:1988;405-412.
35. Ohno T., Kato N., Shimizu M. et al. Effect of age on the development or progression of albuminuria in non-insulin-dependent diabetes mellitus (NIDDM) without hypertension. Diabetes Res. 22:1993;115-121.
36. Allan D.R., McKnight J.A., Kifor I., Coletti C.M., Hollenberg N.K. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension. 24:1994;516-522.
37. Villard E., Tiret L., Visvikis S., Rakotovao R., Cambien F., Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am. J. Hum. Genet. 58:1996;1268-1278.